Last reviewed · How we verify
NCT06723847: LC-RPD
Navigating the Learning Curve of Robotic Pancreatoduodenectomy: Feasibility, Proficiency, and Mastery in a First-generation Surgeon
trial testing Robotic pancreaticoduodenectomy in Robotic Pancreaticoduodenectomy in 313 participants. Completed in 1 June 2024.
1 October 2023
Quick facts
| Lead sponsor | University of Pisa |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 313 |
| Start date | 1 June 2008 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 June 2024 |
Drugs / interventions tested
- Robotic pancreaticoduodenectomy
Conditions studied
- Robotic Pancreaticoduodenectomy — all drugs for Robotic Pancreaticoduodenectomy →
Sponsor
University of Pisa
Who can join
Eligibility, any sex, with Robotic Pancreaticoduodenectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study delineates the learning curve of robotic pancreatoduodenectomy (RPD) for first-generation surgeons, using the Comprehensive Complication Index (CCI) to assess patient outcomes and the PD-ROBOSCORE to stratify patients for their risk to develop post-operative complications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06723847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Robotic pancreaticoduodenectomy
Trials testing the same drug.
- NCT05259384 — Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms · NA · unknown
- NCT04400357 — Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors · NA · completed
Other University of Pisa trials
Trials by the same sponsor.
- NCT07520890 — Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs) · recruiting
- NCT07444229 — Team-Based Learning Integrated Into Clinical Simulation in Nursing Students · NA · not yet recruiting
- NCT07041983 — 24-h Energy Expenditure and Anti-obesity Medication · enrolling by invitation
- NCT07510685 — Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial) · NA · completed
- NCT07055152 — Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06723847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pisa
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06723847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing